Distribution of tumor-infiltrating-T-lymphocytes and possible tumor-escape mechanisms avoiding immune cell attack in locally advanced adenocarcinomas of the esophagus

Bruns, C; Schröder, W; Schlösser, H; Gebauer, F; Schoemmel, M; Loeser, H; Kraemer, M; Wagener-Ryczek, S; Hillmer, A; Buettner, R.
Clin. transl. oncol. (Print) ; 23(8): 1601-1610, ago. 2021. ilus, tab, graf
Artículo en Inglés | IBECS (España) | ID: ibc-222159

Documentos relacionados

  1. Immunogenic characteristics of microsatellite instability-low esophagogastric junction adenocarcinoma based on clinicopathological, molecular, immunological and survival analyses.
  2. Clinico-pathological study of esophageal mucoepidermoid carcinoma: a 10-year survival from a single center.
  3. The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma.
  4. The prognostic impact of tumor length on pathological stage IA-IC esophageal adenocarcinoma.
  5. The Impact of Adjuvant Therapy on Survival After Esophagectomy for Node-negative Esophageal Adenocarcinoma.
  6. High Systemic Immune-Inflammation Index is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma.
  7. Nomograms for predicting overall and recurrence-free survival after trimodality therapy for esophageal adenocarcinoma.
  8. The Impact of Signet Ring Cell Differentiation on Outcome in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma.
  9. Incidence and Prediction of Unrelated Mortality After Successful Endoscopic Eradication Therapy for Barrett's Neoplasia.
  10. Impact of the number of therapy lines on survival in advanced gastric and esophagogastric adenocarcinoma - a real-world retrospective analysis from Croatia.